These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35978777)

  • 1. Executive poverty experience and innovation performance: A study of moderating effects and influencing mechanism.
    Jia X; Wang T; Chen C
    Front Psychol; 2022; 13():946167. PubMed ID: 35978777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of executives' green experience on environmental, social, and governance (ESG) performance: Evidence from China.
    Chen C; Yan Y; Jia X; Wang T; Chai M
    J Environ Manage; 2024 Jul; 366():121819. PubMed ID: 39003908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Scholars-Turned-Businessmen Impact Green Innovation?
    Zhao J; Li W; Zhang Q
    Front Psychol; 2022; 13():920782. PubMed ID: 35795421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employee equity incentive, executive psychological capital, and enterprise innovation.
    Yu L; Hu J
    Front Psychol; 2023; 14():1132550. PubMed ID: 36923141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the Effect of Executive Incentive Institutional Innovation on the Cost of Equity-Evidence From Chinese Listed Companies.
    Wang J; Deng J
    Front Psychol; 2021; 12():686955. PubMed ID: 34168600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of corporate digital strategic orientation on innovation output.
    Fan X; Zhao S; Zhang B; Wang S; Shao D
    Heliyon; 2023 May; 9(5):e16371. PubMed ID: 37251887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do executives' synergistic allocation and organizational slack drive enterprise technological innovation?
    Bai G; Zhao J; Xu P
    PLoS One; 2022; 17(10):e0276022. PubMed ID: 36227881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental cooperation system, ESG performance and corporate green innovation: Empirical evidence from China.
    Qiang S; Gang C; Dawei H
    Front Psychol; 2023; 14():1096419. PubMed ID: 36935950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executives' ESG cognition and enterprise green innovation: Evidence based on executives' personal microblogs.
    Wang D; Luo Y; Hu S; Yang Q
    Front Psychol; 2022; 13():1053105. PubMed ID: 36544446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celebrity CEOs and firm innovation investment: Evidence from Chinese-listed companies.
    Shao D; Lv K; Zhao S; Wang S
    Front Psychol; 2022; 13():978946. PubMed ID: 36478933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of senior executives' overseas experience on corporate green innovation.
    Cheng F; Kuang X
    PLoS One; 2024; 19(5):e0296716. PubMed ID: 38696492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executives' academic experience and corporate social responsibility: A case study in China.
    Yang X; Qi M
    PLoS One; 2024; 19(6):e0305813. PubMed ID: 38917164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the impact mechanism of executives' environmental attention on corporate green transformation: evidence from the textual analysis of Chinese companies' management discussion and analysis.
    Ding X; Xu Z; Petrovskaya MV; Wu K; Ye L; Sun Y; Makarov VM
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76640-76659. PubMed ID: 37237116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of industrial robot adoption on corporate green innovation in China.
    Liang L; Lu L; Su L
    Sci Rep; 2023 Oct; 13(1):18695. PubMed ID: 37907553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family Sibling Effect and Executives' Corporate Social Behavior.
    Zheng M; Ren G; Zhuang L
    Front Psychol; 2021; 12():667529. PubMed ID: 34211422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of technological innovation on corporate leverage in China: The moderating role of policy incentives and market competition.
    Ren L; Liu D; Xiong D
    Front Psychol; 2022; 13():1068375. PubMed ID: 36533031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.